, Majane Agnes Leshoele1
BREAST CANCER AND FERTILITY: WHO's FRAMEWORK FOR REPRODUCTIVE COUNSELING IN YOUNG AFRICAN PATIENTS
Emmanuel Ifeanyi Obeagu*1,2, Majane Agnes Leshoele1
1Division of Haematology, Department of Biomedical and Laboratory Science, Africa University, Zimbabwe.
2The Division of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Abstract
Breast cancer is becoming more acknowledged as a major health issue for young women in Africa, where it is frequently identified at more advanced stages and at a younger age than the worldwide averages. The convergence of breast cancer and fertility creates distinct clinical and psychosocial difficulties, as numerous patients are in their childbearing years and confront the dual pressure of a life-threatening illness and the possible loss of fertility from treatment. Thus, tackling fertility preservation is an essential aspect of holistic cancer treatment for young African women. The World Health Organization (WHO) created a framework to incorporate reproductive counseling into cancer treatment, highlighting early assessment of fertility risks, education for patients, culturally appropriate counseling, and availability of fertility preservation services. Nonetheless, the execution in African contexts is still restricted because of resource limitations, absence of specialized services, socio-cultural obstacles, and inadequate awareness among providers. These difficulties emphasize the necessity for customized approaches that take into account the local health system and cultural environment.
Keywords: Breast cancer, fertility preservation, reproductive counseling, WHO guidelines.
INTRODUCTION
Breast cancer continues to be the most prevalent cancer impacting women globally, with increasing rates in low- and middle-income countries, including numerous African countries1,2. In contrast to high-income areas, where breast cancer mainly impacts postmenopausal women, a significant number of breast cancer patients in Africa are diagnosed at younger ages, frequently before 40 years old. This younger group encounters unique clinical issues, especially related to their reproductive health and potential fertility, which are often neglected in cancer treatment guidelines3,4. The identification of breast cancer in a woman's repro-ductive years can greatly alter her life path, impacting not only her survival but also her capacity to conceive and have children later on. Fertility issues are particularly meaningful in African cultures where being a mother carries deep social and family importance. The possible decline in fertility from gonadotoxic cancer treatments like chemotherapy, radiation, and hormonal therapies brings forth significant psychosocial concerns, affecting treatment choices and quality of life results5,6.
Even with improvements in cancer care, fertility preservation continues to be a neglected concern in numerous African healthcare environments. Restricted availability of fertility preservation options, lack of proper patient guidance, and poor collaboration between oncology and reproductive health services lead to less than ideal care for young breast cancer patients. The lack of structured guidelines designed for African contexts makes it even more difficult to assist patients in making informed reproductive decisions while undergoing cancer treatment7-9. Acknowledging these difficulties, the World Health Organization (WHO) has created an extensive framework to enhance reproductive counseling in cancer treatment, highlig-hting a multidisciplinary approach that honors cultural sensitivities and prioritizes patient autonomy10-12. This framework is designed to assist healthcare professi-onals in identifying fertility risks at an early stage, providing information on possible reproductive choices, and enabling access to fertility preservation strategies when possible. Applying this model in Africa may close current gaps and enhance comprehensive care for young breast cancer survivors.
The epidemiology of breast cancer in Africa, marked by late-stage diagnosis and aggressive tumor biology, highlights the necessity of incorporating fertility counseling into clinical practice. Numerous young women contend with not just the physical impact of cancer but also emotional anguish associated with concerns over infertility and its societal effects. Consequently, reproductive counseling is not just a clinical supplement but a vital part of patient-focused oncology care that fosters mental well-being and enables women in making choices13,14. This review seeks to clarify how breast cancer treatments affect fertility, assess the relevance of the WHO reproductive counseling framework in African settings, and recognize obstacles and prospects for successful implementation.
This review aims to examine the intersection of breast cancer and fertility in young African women, highlighting the implications of cancer treatment on reproductive health.
Epidemiology of breast cancer in young African women
Breast cancer is becoming a significant public health issue in sub-Saharan Africa, with incidence rates increasing consistently over the past few decades. In contrast to trends seen in high-income nations, a notable percentage of breast cancer cases in Africa are identified in women under 40 years old. Epidemiological research shows that about 25–35% of breast cancer patients in African populations are in this younger age category, while around 5–7% are in Western nations. This unique demographic distribution carries significant clinical and psychosocial consequences, especially regarding fertility and survivorship matters16,17. Multiple elements lead to the comparatively younger age at which African women are diagnosed. Genetic factors, including the increased occurrence of aggressive molecular variants like triple-negative breast cancer, could be a contributing factor. Moreover, reproductive and environmental elements like early onset of menstruation, multiple pregnancies, breastfeeding habits, and exposure to pathogens interact in intricate ways to affect risk profiles. Diagnosis at later stages is still frequent, often because of restricted access to screening and diagnostic resources, cultural stigma, and postponements in pursuing medical attention18.
The aggressive tumor biology frequently observed in young African women, coupled with limited treatment resources, results in poorer prognosis and higher mortality rates compared to counterparts in more developed regions. This adverse clinical landscape underscores the urgency of addressing fertility preservation as part of comprehensive cancer management, since many patients face the dual threat of life-threatening disease and potential loss of reproductive capacity18. Moreover, the socio-cultural context amplifies the impact of breast cancer on young African women. Fertility and childbearing are deeply embedded in social identity, marital stability, and community standing. Infertility resulting from cancer treatment can lead to significant psychological distress, marital discord, and social isolation. Thus, epidemiological data underscore the need for integrating fertility counseling and preservation strategies into breast cancer care protocols that are adapted to local realities19.
Impact of breast cancer treatment on fertility
Breast cancer treatment poses significant risks to fertility, particularly for young women who have not yet completed childbearing. The primary modalities used in breast cancer management chemotherapy, radiotherapy, and hormonal therapy can adversely affect ovarian function, leading to temporary or permanent infertility20. Chemotherapy, especially regimens containing alkylating agents like cyclo-phosphamide, is the most common cause of gonadotoxicity in breast cancer patients. These agents induce DNA damage in oocytes and disrupt ovarian follicles, potentially leading to premature ovarian insufficiency (POI). The risk of chemotherapy-induced infertility depends on factors such as patient age, chemotherapy type, dose, and treatment duration. Younger women generally have a higher ovarian reserve and greater resilience; however, even in this group, the risk of amenorrhea and infertility can be substantial21.
Radiationtherapy can also compromise fertility, particularly when pelvic or abdominal fields are involved. While breast radiotherapy primarily targets the chest, incidental exposure or treatment involving lymph nodes near the ovaries can damage ovarian tissue or disrupt the hypothalamic-pituitary-gonadal axis. Additionally, radiation may affect the uterus, reducing its capacity to support pregnancy by impairing endometrial receptivity and vasculariz-ation22. Hormonal therapies, such as tamoxifen and aromatase inhibitors, present unique fertility challenges. These treatments are typically administered for extended periods (5–10 years) to reduce recurrence risk, effectively delaying pregnancy attempts. While not directly gonadotoxic, hormonal therapies necessitate prolonged contraception or treatment interruption, which may complicate family planning. Furthermore, tamoxifen is contraindicated in pregnancy due to teratogenicity23.
In many African healthcare settings, limited access to fertility preservation technologies and specialized reproductive counseling exacerbates the impact of treatment on fertility. The absence of early fertility risk assessment and the lack of multidisciplinary care contribute to missed opportunities for intervention. Furthermore, socio-economic constraints and cultural factors may limit patients’ ability to pursue fertility preservation, making pre-treatment counseling and education even more vital (Table 1)24.
WHO’s framework for reproductive counseling in cancer care
The World Health Organization (WHO) recognizes reproductive health as a fundamental human right and has underscored the importance of integrating fertility counseling into comprehensive cancer care, particularly for young patients at risk of treatment-induced infertility.
In response to the growing need for patient-centered oncological services, WHO developed a framework that provides guidance to healthcare providers on how to address fertility concerns systematically and ethically throughout the cancer treatment continuum25. At the core of the WHO framework is the principle of early and proactive fertility risk assessment. Patients diagnosed with cancers that may impair reproductive function such as breast cancer should be promptly evaluated to identify potential fertility threats associated with planned treatments. This early assessment facilitates timely discussions about risks, fertility preservation options, and informed decision-making before initiating therapy, thereby maximizing the chances of preserving reproductive potential26.
Another key element is comprehensive patient education and counseling. WHO emphasizes that healthcare providers must communicate clearly and compassionately about the impact of cancer treatments on fertility, available preservation techniques, and potential outcomes. Counseling should be individualized, considering the patient’s age, cancer subtype, treatment plan, reproductive goals, and socio-cultural background. This approach promotes shared decision-making, respects patient autonomy, and addresses emotional and psychological dimensions related to fertility loss27. The framework also advocates for equitable access to fertility preservation services, even in resource-limited settings. While advanced technologies like oocyte or embryo cryopreservation may be limited in some African contexts, WHO encourages the use of feasible interventions such as ovarian tissue preservation or temporary ovarian suppression with gonadotropin-releasing hormone analogs. Integration of these services into existing oncology and reproductive health infrastructure is encouraged to reduce barriers and enhance multidisciplinary collaboration28.
Cultural sensitivity and ethical considerations form another pillar of WHO’s framework. Fertility and childbearing hold diverse meanings across societies, and counseling must be tailored to respect cultural values, religious beliefs, and individual patient preferences. This culturally informed approach helps to overcome stigma, misinformation, and social barriers that often hinder fertility discussions in African settings29. WHO highlights the importance of multidisciplinary coordination, involving oncologists, reproductive endocrinologists, psychologists, social workers, and patient advocates. Such teamwork ensures holistic care, addressing not only the medical but also the psychological and social needs of young cancer patients. Effective referral systems and communication pathways between oncology and fertility services are essential components of this integrated care model (Table 2)30.
Challenges to implementation in African contexts
Implementing effective fertility counseling and preservation services for young breast cancer patients in Africa faces numerous complex challenges, many of which are rooted in systemic, socio-cultural, and economic factors unique to the region. These barriers must be carefully addressed to ensure that reproductive health becomes an integral component of cancer care31,32.
Resource constraints and infrastructure limitations:
Many healthcare systems in Africa operate under significant resource limitations, including shortages of specialized medical personnel, lack of fertility preservation technologies, and inadequate laboratory infrastructure.
Facilities equipped for advanced reproductive interventions such as oocyte or embryo cryo-preservation are sparse and often concentrated in urban centers, making access difficult for rural populations. This infrastructural gap restricts the availability of fertility preservation options and limits timely counseling33.
Limited awareness and training among healthcare providers
A pervasive lack of awareness about oncofertility among oncology professionals and primary healthcare workers contributes to inadequate fertility risk assessment and counseling. Training opportunities focused on reproductive health in cancer care are scarce, leading to inconsistent or delayed communication with patients regarding fertility implications of treatment. This knowledge gap undermines patient empowerment and informed decision-making34.
Socio-cultural barriers and stigma
Cultural beliefs and societal norms play a significant role in shaping attitudes toward cancer, fertility, and reproductive choices. In many African communities, infertility can carry profound social consequences, including marital instability and stigmatization. Paradoxically, cultural taboos surrounding discussions of sexuality and reproduction may inhibit open conversations about fertility risks and preservation options. Additionally, misconceptions and myths about cancer and fertility preservation can discourage patients from seeking or accepting these services35.
Economic challenges and cost barriers
The financial burden associated with fertility preservation procedures is a significant obstacle for many patients. Without insurance coverage or subsidized care, the high out-of-pocket costs for technologies such as cryopreservation are often prohibitive. In countries where healthcare financing relies heavily on direct payments, economic inequities exacerbate disparities in access to fertility preservation36.
Fragmented healthcare systems and referral pathways
Poor coordination between oncology services and reproductive health specialists impedes seamless integration of fertility counseling into cancer care. Fragmented health systems with weak referral mechanisms result in missed opportunities for timely fertility risk assessment and intervention. This disjointed approach compromises the continuity and quality of patient care37.
Limited data and research
The paucity of region-specific data on fertility outcomes, patient preferences, and effective preservation methods hampers evidence-based policy and program development. Without robust research, interventions may not be appropriately tailored to the needs of African breast cancer patients, limiting their efficacy and sustainability. Addressing these challenges requires a concerted effort from governments, healthcare providers, communities, and international partners. Overcoming systemic, cultural, and economic barriers is essential to realizing WHO’s vision for comprehensive reproductive counseling and fertility preservation in cancer care, thereby improving survivorship and quality of life for young African women with breast cancer38,39.
Strategies to improve fertility counseling and preservation
Enhancing fertility counseling and preservation services for young African breast cancer patients requires a multifaceted approach tailored to the unique socio-economic and cultural realities of the region. Addressing existing barriers involves strengthening healthcare systems, building provider capacity, and fostering patient empowerment through education and supportive policies40-42.
1. Capacity building and provider training:
One of the most critical steps is equipping healthcare providers with the knowledge and skills necessary to discuss fertility risks and preservation options confidently and empathetically. Training programs should be integrated into oncology, gynecology, and primary care curricula, focusing on oncofertility principles, counseling techniques, and the use of available preservation methods. Continuous professional development and mentorship can further sustain provider competence and motivation43,44.
2. Development of national and institutional policies:
Policy frameworks that formally recognize fertility preservation as an essential component of cancer care are vital. National cancer control plans should incorporate guidelines aligned with WHO recommend-dations, ensuring standardized fertility risk assessment and counseling practices across healthcare facilities. Policies can also address financial coverage for fertility preservation procedures, reducing economic barriers that disproportionately affect patients in low-resource settings45,46.
3. Infrastructure enhancement and service integration:
Establishing or expanding fertility preservation services within existing healthcare facilities is crucial. This includes investing in affordable technologies such as ovarian tissue cryopreservation and promoting referral networks between oncology and reproductive health specialists. Integrating fertility counseling into routine cancer care pathways fosters timely interventions and reduces fragmentation of services47,48.
4. Culturally sensitive patient education and community engagement:
Patient-centered educational materials, delivered in local languages and sensitive to cultural beliefs, can demystify fertility preservation and reduce stigma. Community health workers and patient advocates play key roles in raising awareness, encouraging early medical consultation, and supporting adherence to fertility preservation plans. Engagement with religious and community leaders can further facilitate acceptance and dissemination of accurate information49.
5. Research and data collection:
Building a robust evidence base through local research is essential for understanding fertility preservation needs, outcomes, and barriers in African populations. Collecting epidemiological and clinical data can guide resource allocation, policy formulation, and the development of context-appropriate interventions50.
6. Psychological support and counseling services:
Addressing the emotional and psychological impact of potential infertility is integral to comprehensive care. Incorporating mental health professionals into oncology teams provides patients with coping strategies, supports decision-making, and mitigates distress related to fertility loss51.
7. Leveraging international collaboration and funding:
Partnerships with international organizations, academic institutions, and funding bodies can provide technical expertise, training, and financial resources. Such collaborations can accelerate the introduction of innovative fertility preservation techniques and capacity-building initiatives in African healthcare systems44.
CONCLUSIONS
Breast cancer in young African women presents unique challenges that extend beyond oncological management to encompass vital reproductive health concerns. The potential impact of cancer treatments on fertility underscores the need for integrating comprehensive reproductive counseling and fertility preservation services into routine cancer care. The World Health Organization’s framework offers a valuable, culturally sensitive model for addressing these needs through early risk assessment, patient education, multidisciplinary collaboration, and equitable access to fertility preservation options. However, the successful implementation of this framework in African contexts is hindered by resource limitations, healthcare system fragmentation, socio-cultural barriers, and economic constraints. Overcoming these obstacles demands strategic investments in healthcare infrastructure, capacity building, policy development, and community engagement to ensure that fertility preservation becomes an accessible and integral part of breast cancer care.
ACKNOWLEDGEMENTS
The authors express their gratitude to Africa University, Mutare, Zimbabwe to provide necessary facilities for this work.
AUTHOR'S CONTRIBUTION
Obeagu EI: conceived the idea, writing the manuscript, literature survey. Leshoele MA: formal analysis, data processing. Final manuscript was checked and approved by both authors.
DATA AVAILABILITY
The empirical data used to support the study's conclusions are available upon request from the corresponding author.
CONFLICTS OF INTEREST
The authors declare no conflict of interest
REFERENCES